AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimimore MF 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimimore MF 1mg/500mg Tablet SR

Diabetic patients using Glimimore MF 1mg/500mg SR tablets, a dual-action antidiabetic medication, should adhere to prescribed dosage and timing. This combination therapy effectively manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake, ideally with meals, maximizes efficacy. Dosage adjustments are determined by your physician based on blood sugar monitoring. Discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control, as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Regular meals, readily available glucose sources (e.g., sugary snacks, juice), and alcohol avoidance mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (including complete blood count and liver function tests) are crucial for effective management.

Uses of Glimimore MF 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimimore MF 1mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimimore MF 1mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

Common Side effects of Glimimore MF 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimimore MF 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimimore MF 1mg/500mg Extended-Release Tablet with a meal.

How Glimimore MF 1mg/500mg Tablet SR works:

Glimepiride and Metformin, combined as Glimimore MF 1mg/500mg SR tablets, offer dual-action blood glucose control. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood sugar. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimimore MF 1mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimimore MF 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimimore MF 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimimore MF 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimimore MF 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimimore MF 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimimore MF 1mg/500mg Tablet SR :

Should you forget a dose of Glimimore MF 1mg/500mg SR Tablet, take it immediately if you remember. But, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimimore MF 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimimore MF 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimimore MF 1mg/500mg Tablet SR can cause lactic acidosis, a serious, potentially fatal condition characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is particularly risky for individuals with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimimore MF 1mg/500mg Tablet SR and seek immediate medical attention.
Glimimore MF 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimimore MF 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimimore MF 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glimimore MF 1mg/500mg Tablet SR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimimore MF 1mg/500mg Tablet SR with alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimimore MF 1mg/500mg Ta...
52
MRP 63
17% off